Sus Clinicals - Crunchbase Company Profile & Funding

Q: Where is Sus Clinicals's headquarters?

Sus Clinicals is located in Cincinnati, Ohio, United States.

Q: When was the last funding round for Sus Clinicals?

Sus Clinicals closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Sus Clinicals raised to date?

Sus Clinicals has raised obfuscated.

Overview

Sus Clinicals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Sus Clinicals

CB Rank

95281

Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.

Founded

obfuscation

Private

Seed

Cincinnati, Ohio, United States

1-10

susclinicals.com

Biotechnology

Pharmaceutical

Product Research

Funding Rounds

Seed

OBF

obfuscation

Key People

Jeffrey D. Weedman: Chief Executive Officer and Co-Founder
Lawrence Schook: Chief Scientific Officer and Co-Founder
Past Role: University of Illinois Urbana-Champaign, Vice President of Research

Details

Legal Name

Sus Clinicals, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Jeffrey D. Weedman, Lawrence Schook

Contact Email

info@susclinicals.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Oncopig Cancer Model®

A genetically engineered pig model that allows induction of relevant tumors on demand for preclinical testing of cancer drugs, devices, and diagnostics.

Genetically Defined Cell Lines

Cell lines derived from the Oncopig model used for in vitro cancer research and drug testing.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Sus Clinicals	—	obfuscated obfuscation	—	Seed